The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07513883

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07513883
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07513883. Randomized; single masking; primary purpose treatment. Start 2026-03-16 (actual); primary completion 2028-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.
Acronym
TAPERED-HF
Condition
Heart Failure
Intervention (Drug)
Down-titration
Intervention (Drug)
Continuation of guideline-directed heart failure therapy
Lead sponsor
Ziekenhuis Oost-Limburg (class: other)

Record details

Record id
cardio:ct-nct07513883
Content hash
af23e4a05393efbce70ffcf34409fae2db19e9e0c85c8eeec66d6c3eaea01447